Alpha Lipoic Acid Against Cardiovascular Events in Patients With Haemodialysis
Condition(s):Hemodialysis ComplicationLast Updated:December 26, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Hemodialysis ComplicationLast Updated:December 26, 2019Completed
Condition(s):Metabolic SyndromeLast Updated:July 18, 2018Unknown status
Condition(s):Diabetic NeuropathyLast Updated:March 2, 2016Completed
Condition(s):ToxicityLast Updated:May 10, 2016Unknown status
Condition(s):Obstructive Sleep Apnea of AdultLast Updated:May 25, 2022Recruiting
Condition(s):Metabolic Syndrome; ObesityLast Updated:November 17, 2017Completed
Condition(s):Peripheral NeuropathyLast Updated:October 2, 2014Completed
Condition(s):Multiple Sclerosis; Progressive Multiple Sclerosis; Secondary Progressive Multiple Sclerosis; Primary Progressive Multiple SclerosisLast Updated:March 22, 2019Completed
Condition(s):Obesity; Weight Loss; SchizophreniaLast Updated:November 5, 2015Completed
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:July 7, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.